Cookie Policy

By clicking "Accept", you are agreeing to continue browsing and accept the website privacy policy.

Responsive image

Drug Information

Drug Generic Name TRANEXAMIC ACID
Drug Class FIBRINOLYTIC DRUGS, ANTI-FIBRINOLYTIC DRUGS AND HAEMOSTATICS
Chapter Cardiovascular System

Indications: it inhibits plasminogen activation and fibrinolysis. It may be useful when haemorrhage cannot be stopped as in prostatectomy, dental extraction in haemophiliacs, or menorrhagia; also can be used in hereditary angioedema and in thrombolytic overdose. Cautions: reduce dose in renal impairment; massive haematuria (ureteric obstruction); regular eye examinations and liver function test in long-term treatment of hereditary angioedema.

Contra-indications: thromboembolic disease; severe renal impairment.

Side Effects: nausea, vomiting, diarrhoea (reduce dose); giddiness on rapid injection; disturbances in colour vision (discontinue)

Dose: by mouth, 1 -1.5 g 2-4 times daily.

By slow IV injection, 0.5 0 1 g 3 times daily for local fibrinolysis.

Brand Name
  • Cyclokapron Injection 100 mg/ml
  • Cyclokapron Tablets 500 mg
rating - 1 starrating - 2 starrating - 3 starrating - 4 starrating - 5 star